BRCA1 5382insC Mutation in Breast and Ovarian Cancer
Author Information
Author(s): P Mullen, WR Miller, J Mackay, DR Fitzpatrick, SP Langdon, JP Warner
Primary Institution: Imperial Cancer Research Fund, Medical Oncology Unit; University Department of Human Genetics, Western General Hospital
Hypothesis
The incidence of the BRCA1 5382insC mutation might be considerably higher for women with breast cancer within a Scottish population.
Conclusion
The study found a low but significant incidence of the BRCA1 5382insC mutation in sporadic breast cancer patients.
Supporting Evidence
- Only one out of 250 breast cancer patients tested positive for the BRCA1 5382insC mutation.
- None of the 80 ovarian cancer patients tested had the mutation.
- The single positive case was a 26-year-old woman with no known family history.
Takeaway
The researchers looked for a specific gene mutation in women with breast and ovarian cancer and found it in only one breast cancer patient.
Methodology
A restriction site-generating polymerase chain reaction (RG-PCR) assay was developed to detect the BRCA1 5382insC mutation in tumor DNA from breast and ovarian cancer patients.
Limitations
The study only identified one case of the mutation in a small sample of sporadic breast cancer patients.
Participant Demographics
The study included 250 breast cancer patients aged 19-86 years and 80 ovarian cancer patients aged 25-90 years, with no known family history of cancer.
Want to read the original?
Access the complete publication on the publisher's website